terizidone

Small moleculeexperimental

Terizidone is a drug used in the treatment of tuberculosis. Terizidone is mainly used in multi-drug-resistant tuberculosis (MDR-TB) in conjunction with other second-line drugs. It is a derivative of cycloserine with bacteriostatic activity. — Wikipedia

Clinical trial activity

2 trials · 7 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
1

Earliest trial started Mar 1, 2003 (NCT00042289)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

O=C1NOCC1/N=C/c1ccc(/C=N/C2CONC2=O)cc1
Mol. weight
302.29 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Racemic Mixture
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 4,4'-(p-phenylenebis(methyleneimino))bis-3-isoxazolidone
  • terazolidone
  • terivalidin
  • terivalidin
  • terivalidine
  • terizidon
  • terizidon
  • terizidone
  • terizidone
  • terizidone
  • terizidone
  • terizidone
  • terizidone
  • terizidone
  • terizidone
  • terizidone, calcium salt, (r-(r*,r*))-isomer

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02454205Phase 2/Phase 3 (Phase 3)Oct 1, 2015Stellenbosch University, University of Cape Town, University of Limpopo, Walter Sisulu University
NCT00042289Phase 4Mar 1, 2003Boston University, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Boston UniversityAcademic/Hospital1012003
National Institute of Allergy and Infectious Diseases (NIAID)Government1112003
National Institutes of Health (NIH)Government1012003
Stellenbosch UniversityAcademic/Hospital1012015
University of Cape TownAcademic/Hospital1112015
University of LimpopoAcademic/Hospital1012015
Walter Sisulu UniversityAcademic/Hospital1012015
7 organizations
Page 1 / 1